Status:
UNKNOWN
Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery
Lead Sponsor:
Seoul National University Hospital
Conditions:
Retinal Disease
Epiretinal Membrane
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The patients who are diagnosed with idiopathic epiretinal membrane and scheduled to undergo epiretinal membrane removal will be treated with conventional vitrectomy and the epiretinal membrane will be...
Eligibility Criteria
Inclusion
- Age equal to or older than 19 years
- Patients diagnosed with idiopathic epiretinal membrane and scheduled to undergo the epiretinal membrane removal surgery
Exclusion
- Accompanied with retinal vascular disease or intraocular inflammation
- Prior treatment with vitrectomy in the study eye
- History of glaucoma
Key Trial Info
Start Date :
September 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04130841
Start Date
September 30 2019
End Date
December 31 2021
Last Update
September 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080